Natixis Advisors’s Global Cord Blood Corporation CO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-200,914
| Closed | -$211K | – | 1550 |
|
|
2023
Q2 | $211K | Sell |
200,914
-237
| -0.1% | -$249 | ﹤0.01% | 1460 |
|
|
2023
Q1 | $601K | Hold |
201,151
| – | – | ﹤0.01% | 1267 |
|
|
2022
Q4 | $601K | Hold |
201,151
| – | – | ﹤0.01% | 1265 |
|
|
2022
Q3 | $601K | Buy |
201,151
+1,271
| +0.6% | +$3.8K | ﹤0.01% | 1242 |
|
|
2022
Q2 | $592K | Buy |
199,880
+10,550
| +6% | +$31.2K | ﹤0.01% | 1241 |
|
|
2022
Q1 | $729K | Buy |
189,330
+11,709
| +7% | +$45.1K | ﹤0.01% | 1203 |
|
|
2021
Q4 | $744K | Buy |
177,621
+3,052
| +2% | +$12.8K | ﹤0.01% | 1176 |
|
|
2021
Q3 | $815K | Buy |
174,569
+3,680
| +2% | +$17.2K | ﹤0.01% | 1124 |
|
|
2021
Q2 | $913K | Hold |
170,889
| – | – | ﹤0.01% | 1113 |
|
|
2021
Q1 | $774K | Buy |
+170,889
| New | +$774K | ﹤0.01% | 1100 |
|